| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Triple Negative Breast Neoplasms | 7 | 2024 | 261 | 1.450 |
Why?
|
| Proto-Oncogene Proteins c-myc | 6 | 2024 | 216 | 1.410 |
Why?
|
| Breast Neoplasms | 18 | 2025 | 2752 | 1.370 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 2016 | 645 | 0.960 |
Why?
|
| Repressor Proteins | 7 | 2016 | 862 | 0.950 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 2 | 2018 | 19 | 0.940 |
Why?
|
| Cell Line, Tumor | 28 | 2025 | 3704 | 0.900 |
Why?
|
| Ribonucleotides | 1 | 2024 | 36 | 0.900 |
Why?
|
| RNA Stability | 1 | 2024 | 84 | 0.880 |
Why?
|
| RNA Interference | 12 | 2018 | 544 | 0.770 |
Why?
|
| Genes, myc | 4 | 2021 | 107 | 0.570 |
Why?
|
| Transcription, Genetic | 6 | 2020 | 1752 | 0.570 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 495 | 0.490 |
Why?
|
| Gene Expression Regulation, Neoplastic | 12 | 2025 | 2110 | 0.480 |
Why?
|
| Mice | 32 | 2025 | 18709 | 0.450 |
Why?
|
| Animals | 39 | 2025 | 36116 | 0.410 |
Why?
|
| Transcription Factors | 5 | 2021 | 2700 | 0.410 |
Why?
|
| Signal Transduction | 11 | 2021 | 4867 | 0.390 |
Why?
|
| Phosphorylation | 8 | 2020 | 1700 | 0.380 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2011 | 23 | 0.380 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2013 | 506 | 0.370 |
Why?
|
| Xenograft Model Antitumor Assays | 9 | 2021 | 975 | 0.370 |
Why?
|
| Molecular Targeted Therapy | 5 | 2021 | 403 | 0.360 |
Why?
|
| Neoplasm Metastasis | 6 | 2025 | 749 | 0.350 |
Why?
|
| Mice, Nude | 7 | 2021 | 776 | 0.340 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 2008 | 4 | 0.300 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2008 | 20 | 0.290 |
Why?
|
| Spliceosomes | 2 | 2021 | 57 | 0.290 |
Why?
|
| TOR Serine-Threonine Kinases | 5 | 2017 | 458 | 0.280 |
Why?
|
| Proteogenomics | 2 | 2020 | 95 | 0.280 |
Why?
|
| GATA6 Transcription Factor | 2 | 2020 | 13 | 0.270 |
Why?
|
| Oncogene Proteins, Viral | 4 | 2008 | 68 | 0.270 |
Why?
|
| RNA, Double-Stranded | 2 | 2024 | 66 | 0.270 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2021 | 224 | 0.270 |
Why?
|
| Papillomaviridae | 3 | 2002 | 189 | 0.270 |
Why?
|
| Carcinogenesis | 3 | 2020 | 361 | 0.260 |
Why?
|
| alpha-Synuclein | 2 | 2018 | 132 | 0.260 |
Why?
|
| Tumor Microenvironment | 4 | 2020 | 650 | 0.250 |
Why?
|
| Taxoids | 2 | 2024 | 72 | 0.250 |
Why?
|
| CDC2-CDC28 Kinases | 2 | 2002 | 21 | 0.250 |
Why?
|
| Cell Differentiation | 5 | 2023 | 2025 | 0.240 |
Why?
|
| N-Terminal Acetyltransferase E | 1 | 2025 | 10 | 0.240 |
Why?
|
| Humans | 48 | 2025 | 132393 | 0.240 |
Why?
|
| Female | 30 | 2025 | 70660 | 0.240 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2017 | 359 | 0.240 |
Why?
|
| Pyroptosis | 1 | 2024 | 28 | 0.230 |
Why?
|
| Blood Proteins | 1 | 2025 | 133 | 0.220 |
Why?
|
| Endoribonucleases | 1 | 2024 | 77 | 0.220 |
Why?
|
| tau Proteins | 2 | 2016 | 230 | 0.220 |
Why?
|
| Neurons | 2 | 2018 | 2022 | 0.210 |
Why?
|
| Multifactorial Inheritance | 1 | 2025 | 158 | 0.210 |
Why?
|
| RNA, Small Interfering | 6 | 2018 | 714 | 0.210 |
Why?
|
| Lysine | 3 | 2019 | 204 | 0.210 |
Why?
|
| Cyclins | 2 | 2002 | 104 | 0.200 |
Why?
|
| Spindle Apparatus | 2 | 2014 | 50 | 0.200 |
Why?
|
| Cell Adhesion Molecules | 2 | 2015 | 247 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2002 | 19 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2017 | 512 | 0.200 |
Why?
|
| Cell Proliferation | 8 | 2025 | 2532 | 0.190 |
Why?
|
| Colitis, Ulcerative | 1 | 2025 | 216 | 0.190 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2014 | 598 | 0.190 |
Why?
|
| Gene Amplification | 3 | 2021 | 247 | 0.180 |
Why?
|
| Crohn Disease | 1 | 2025 | 286 | 0.180 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2023 | 157 | 0.180 |
Why?
|
| Cell Survival | 4 | 2018 | 890 | 0.180 |
Why?
|
| STAT3 Transcription Factor | 2 | 2014 | 230 | 0.180 |
Why?
|
| Neoplasms | 3 | 2018 | 2984 | 0.180 |
Why?
|
| Transcription Factor RelA | 1 | 2021 | 56 | 0.180 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2020 | 608 | 0.180 |
Why?
|
| Supratentorial Neoplasms | 1 | 2021 | 39 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2020 | 31 | 0.170 |
Why?
|
| Proteomics | 1 | 2025 | 580 | 0.170 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2020 | 39 | 0.170 |
Why?
|
| ras Proteins | 2 | 2013 | 144 | 0.170 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2020 | 177 | 0.170 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2020 | 19 | 0.170 |
Why?
|
| Histones | 3 | 2019 | 566 | 0.170 |
Why?
|
| Keratinocytes | 3 | 2014 | 69 | 0.160 |
Why?
|
| Mitosis | 2 | 2011 | 194 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2025 | 3443 | 0.160 |
Why?
|
| Lipid Peroxidation | 1 | 2020 | 98 | 0.160 |
Why?
|
| Myeloid-Derived Suppressor Cells | 2 | 2019 | 51 | 0.160 |
Why?
|
| Immunity | 1 | 2021 | 202 | 0.160 |
Why?
|
| Computational Biology | 1 | 2025 | 881 | 0.160 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 608 | 0.160 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2020 | 101 | 0.160 |
Why?
|
| Receptor, ErbB-2 | 2 | 2020 | 559 | 0.160 |
Why?
|
| Ependymoma | 1 | 2021 | 172 | 0.160 |
Why?
|
| HMGN1 Protein | 1 | 2018 | 3 | 0.150 |
Why?
|
| Mutation | 5 | 2018 | 6233 | 0.150 |
Why?
|
| Protein Kinases | 2 | 2020 | 342 | 0.150 |
Why?
|
| Reperfusion Injury | 1 | 2020 | 124 | 0.150 |
Why?
|
| Myeloid Cells | 1 | 2019 | 109 | 0.150 |
Why?
|
| Genome | 2 | 2018 | 520 | 0.150 |
Why?
|
| Cell Movement | 3 | 2025 | 918 | 0.150 |
Why?
|
| Genetic Testing | 1 | 2005 | 1074 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 176 | 0.150 |
Why?
|
| Trisomy | 1 | 2018 | 112 | 0.150 |
Why?
|
| Phosphofructokinase-2 | 1 | 2018 | 25 | 0.150 |
Why?
|
| Lung Neoplasms | 3 | 2020 | 1778 | 0.150 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2018 | 65 | 0.140 |
Why?
|
| Immunotherapy | 2 | 2020 | 730 | 0.140 |
Why?
|
| Receptors, Androgen | 1 | 2020 | 430 | 0.140 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2018 | 142 | 0.140 |
Why?
|
| Aneuploidy | 1 | 2018 | 145 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2011 | 384 | 0.140 |
Why?
|
| Transcriptional Activation | 2 | 2018 | 496 | 0.140 |
Why?
|
| Glucose | 2 | 2020 | 916 | 0.130 |
Why?
|
| Cell Cycle Proteins | 3 | 2014 | 694 | 0.130 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 598 | 0.130 |
Why?
|
| DNA-Binding Proteins | 3 | 2021 | 2144 | 0.130 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2016 | 16 | 0.130 |
Why?
|
| DNA Damage | 2 | 2020 | 541 | 0.130 |
Why?
|
| Cell Cycle | 3 | 2011 | 628 | 0.130 |
Why?
|
| DNA Repair | 2 | 2020 | 626 | 0.130 |
Why?
|
| Disease Models, Animal | 8 | 2021 | 4699 | 0.120 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2018 | 350 | 0.120 |
Why?
|
| Down Syndrome | 1 | 2018 | 226 | 0.120 |
Why?
|
| Colonic Neoplasms | 2 | 2009 | 267 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2014 | 214 | 0.120 |
Why?
|
| Tauopathies | 1 | 2016 | 68 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 428 | 0.120 |
Why?
|
| Brain Neoplasms | 1 | 2025 | 1377 | 0.120 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2015 | 25 | 0.120 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2015 | 64 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 124 | 0.110 |
Why?
|
| Re-Epithelialization | 1 | 2014 | 12 | 0.110 |
Why?
|
| Lipocalins | 1 | 2014 | 30 | 0.110 |
Why?
|
| Wilms Tumor | 1 | 2015 | 118 | 0.110 |
Why?
|
| Acute-Phase Proteins | 1 | 2014 | 50 | 0.110 |
Why?
|
| Transplantation, Heterologous | 2 | 2011 | 271 | 0.110 |
Why?
|
| Nuclear Proteins | 3 | 2018 | 1328 | 0.110 |
Why?
|
| Glutarates | 1 | 2013 | 38 | 0.110 |
Why?
|
| Cell Nucleus | 1 | 2016 | 688 | 0.110 |
Why?
|
| Neoplasm Transplantation | 2 | 2011 | 398 | 0.110 |
Why?
|
| Genetic Markers | 1 | 2015 | 630 | 0.110 |
Why?
|
| Osteogenesis | 1 | 2015 | 167 | 0.110 |
Why?
|
| Proteolysis | 1 | 2014 | 187 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2016 | 521 | 0.110 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 149 | 0.110 |
Why?
|
| Cell Polarity | 1 | 2014 | 126 | 0.100 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2013 | 38 | 0.100 |
Why?
|
| Mammary Glands, Animal | 2 | 2014 | 476 | 0.100 |
Why?
|
| Gene Library | 3 | 2018 | 226 | 0.100 |
Why?
|
| Antigens, CD | 1 | 2015 | 450 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 2 | 2013 | 324 | 0.100 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 2656 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 1402 | 0.100 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 271 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 265 | 0.100 |
Why?
|
| Sirolimus | 1 | 2014 | 242 | 0.100 |
Why?
|
| Neuroblastoma | 1 | 2018 | 538 | 0.100 |
Why?
|
| Cell Communication | 1 | 2013 | 186 | 0.100 |
Why?
|
| MCF-7 Cells | 3 | 2020 | 231 | 0.090 |
Why?
|
| Papillomavirus E7 Proteins | 4 | 2008 | 24 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 406 | 0.090 |
Why?
|
| Sumoylation | 1 | 2011 | 38 | 0.090 |
Why?
|
| Genomics | 3 | 2018 | 1658 | 0.090 |
Why?
|
| Genetic Vectors | 3 | 2011 | 964 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 459 | 0.090 |
Why?
|
| Skin | 1 | 2014 | 550 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 138 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2019 | 803 | 0.090 |
Why?
|
| Lentivirus | 1 | 2011 | 86 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 465 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2016 | 3164 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2013 | 714 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 716 | 0.090 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2013 | 254 | 0.090 |
Why?
|
| Genetic Techniques | 1 | 2011 | 109 | 0.090 |
Why?
|
| Wound Healing | 1 | 2014 | 487 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 246 | 0.080 |
Why?
|
| Chromatin | 3 | 2020 | 608 | 0.080 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 453 | 0.080 |
Why?
|
| Substrate Specificity | 2 | 2008 | 310 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 585 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 349 | 0.080 |
Why?
|
| Mice, SCID | 3 | 2018 | 612 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 2 | 2013 | 1156 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2011 | 302 | 0.080 |
Why?
|
| Protein Methyltransferases | 1 | 2008 | 9 | 0.080 |
Why?
|
| HEK293 Cells | 3 | 2018 | 798 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 1903 | 0.080 |
Why?
|
| Receptors, Estrogen | 3 | 2018 | 822 | 0.070 |
Why?
|
| Cerebellar Neoplasms | 1 | 2012 | 456 | 0.070 |
Why?
|
| Drosophila melanogaster | 1 | 2013 | 823 | 0.070 |
Why?
|
| Introns | 2 | 2021 | 313 | 0.070 |
Why?
|
| Genes, Neoplasm | 1 | 2008 | 90 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2008 | 298 | 0.070 |
Why?
|
| Ubiquitin | 1 | 2008 | 147 | 0.070 |
Why?
|
| Oncogenes | 2 | 2018 | 179 | 0.070 |
Why?
|
| Medulloblastoma | 1 | 2012 | 565 | 0.070 |
Why?
|
| RNA Splicing | 2 | 2021 | 250 | 0.070 |
Why?
|
| Retinoblastoma Protein | 3 | 2020 | 86 | 0.070 |
Why?
|
| MicroRNAs | 2 | 2011 | 944 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2019 | 906 | 0.060 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 316 | 0.060 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2022 | 170 | 0.060 |
Why?
|
| 3T3 Cells | 2 | 2002 | 123 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 1071 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2002 | 52 | 0.060 |
Why?
|
| N-Terminal Acetyltransferases | 1 | 2025 | 1 | 0.060 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2002 | 90 | 0.060 |
Why?
|
| Epithelium | 3 | 2014 | 370 | 0.060 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2025 | 6 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2016 | 433 | 0.060 |
Why?
|
| Cell Lineage | 2 | 2020 | 366 | 0.060 |
Why?
|
| Transaminases | 1 | 2025 | 35 | 0.060 |
Why?
|
| Bridged-Ring Compounds | 1 | 2024 | 17 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 2494 | 0.060 |
Why?
|
| Methylation | 2 | 2019 | 231 | 0.060 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2005 | 109 | 0.060 |
Why?
|
| Epithelial Cells | 2 | 2008 | 938 | 0.060 |
Why?
|
| United Kingdom | 1 | 2025 | 235 | 0.060 |
Why?
|
| Cell Division | 2 | 2002 | 772 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 4728 | 0.050 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2024 | 130 | 0.050 |
Why?
|
| Cell Death | 2 | 2021 | 249 | 0.050 |
Why?
|
| Cell Line | 3 | 2018 | 2836 | 0.050 |
Why?
|
| Drug Design | 1 | 2005 | 167 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2024 | 131 | 0.050 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2024 | 122 | 0.050 |
Why?
|
| Genetic Engineering | 1 | 2004 | 164 | 0.050 |
Why?
|
| Proteins | 1 | 2008 | 1086 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 395 | 0.050 |
Why?
|
| Cyclin E | 1 | 2002 | 33 | 0.050 |
Why?
|
| Drosophila | 2 | 2018 | 815 | 0.050 |
Why?
|
| Apoptosis | 3 | 2021 | 1926 | 0.050 |
Why?
|
| Inflammasomes | 1 | 2024 | 162 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2002 | 90 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2005 | 481 | 0.050 |
Why?
|
| DNA Methylation | 2 | 2023 | 1140 | 0.050 |
Why?
|
| cdc25 Phosphatases | 1 | 2002 | 20 | 0.050 |
Why?
|
| Tumor Burden | 2 | 2013 | 257 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2017 | 1593 | 0.050 |
Why?
|
| Genital Neoplasms, Male | 1 | 2001 | 12 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 3045 | 0.040 |
Why?
|
| APOBEC Deaminases | 1 | 2020 | 7 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 1131 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2015 | 827 | 0.040 |
Why?
|
| Genital Neoplasms, Female | 1 | 2001 | 47 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2025 | 322 | 0.040 |
Why?
|
| Adenosine | 1 | 2021 | 136 | 0.040 |
Why?
|
| Cyclohexylamines | 1 | 2020 | 6 | 0.040 |
Why?
|
| Viral Envelope Proteins | 1 | 2001 | 155 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 96 | 0.040 |
Why?
|
| A549 Cells | 1 | 2020 | 49 | 0.040 |
Why?
|
| Phenylenediamines | 1 | 2020 | 25 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2020 | 67 | 0.040 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2019 | 27 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 244 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2021 | 303 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 109 | 0.040 |
Why?
|
| Retroelements | 1 | 2019 | 41 | 0.040 |
Why?
|
| Transcriptome | 2 | 2018 | 1104 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2020 | 352 | 0.040 |
Why?
|
| Granulocytes | 1 | 2019 | 70 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2019 | 67 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 590 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 794 | 0.040 |
Why?
|
| Trastuzumab | 1 | 2019 | 154 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2019 | 114 | 0.040 |
Why?
|
| Binding Sites | 2 | 2018 | 1365 | 0.040 |
Why?
|
| Alzheimer Disease | 2 | 2016 | 851 | 0.040 |
Why?
|
| Nucleosomes | 1 | 2018 | 40 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2014 | 12861 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2023 | 562 | 0.040 |
Why?
|
| Phosphoserine | 1 | 2018 | 42 | 0.040 |
Why?
|
| Transketolase | 1 | 2018 | 19 | 0.040 |
Why?
|
| Acetylation | 1 | 2018 | 182 | 0.040 |
Why?
|
| Keratins | 1 | 2018 | 52 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 35 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 44 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2021 | 676 | 0.040 |
Why?
|
| Piperazines | 1 | 2020 | 256 | 0.040 |
Why?
|
| Gene Expression | 2 | 2014 | 1614 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 1083 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2018 | 1413 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2018 | 39 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2020 | 268 | 0.040 |
Why?
|
| E2F1 Transcription Factor | 1 | 2018 | 51 | 0.040 |
Why?
|
| Purines | 1 | 2018 | 119 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 464 | 0.040 |
Why?
|
| Species Specificity | 1 | 2018 | 571 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2018 | 220 | 0.030 |
Why?
|
| Chromosomes | 1 | 2018 | 165 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 171 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2020 | 326 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2020 | 1127 | 0.030 |
Why?
|
| Iron | 1 | 2020 | 302 | 0.030 |
Why?
|
| Metabolomics | 1 | 2020 | 448 | 0.030 |
Why?
|
| Neutrophils | 1 | 2019 | 403 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2020 | 412 | 0.030 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2016 | 34 | 0.030 |
Why?
|
| Prognosis | 2 | 2018 | 5029 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 317 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2018 | 315 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2014 | 3933 | 0.030 |
Why?
|
| Splicing Factor U2AF | 1 | 2015 | 12 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 11 | 0.030 |
Why?
|
| Protein Binding | 3 | 2008 | 1830 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 93 | 0.030 |
Why?
|
| Kinetics | 1 | 2018 | 1349 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 548 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2018 | 789 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 2916 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 66 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 54 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2020 | 913 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2015 | 65 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2025 | 3621 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2018 | 1124 | 0.030 |
Why?
|
| Fear | 1 | 2016 | 207 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2015 | 63 | 0.030 |
Why?
|
| Carboplatin | 1 | 2015 | 87 | 0.030 |
Why?
|
| RNA | 1 | 2018 | 602 | 0.030 |
Why?
|
| Macrophages | 1 | 2019 | 693 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 1044 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2001 | 866 | 0.030 |
Why?
|
| Male | 5 | 2025 | 64985 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2020 | 806 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2017 | 500 | 0.030 |
Why?
|
| Lipocalin-2 | 1 | 2014 | 32 | 0.030 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2014 | 101 | 0.030 |
Why?
|
| Models, Biological | 1 | 2019 | 1531 | 0.030 |
Why?
|
| Middle Aged | 3 | 2025 | 28944 | 0.030 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2013 | 22 | 0.030 |
Why?
|
| Doxycycline | 1 | 2014 | 121 | 0.030 |
Why?
|
| Cadherins | 1 | 2015 | 184 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2015 | 2894 | 0.030 |
Why?
|
| Nectins | 1 | 2013 | 1 | 0.030 |
Why?
|
| Integrin beta4 | 1 | 2013 | 3 | 0.030 |
Why?
|
| Ataxins | 1 | 2013 | 114 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2015 | 453 | 0.030 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2013 | 80 | 0.030 |
Why?
|
| Protein Stability | 1 | 2013 | 172 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2014 | 374 | 0.030 |
Why?
|
| beta Catenin | 1 | 2014 | 229 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2013 | 98 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 1069 | 0.020 |
Why?
|
| Ataxin-1 | 1 | 2013 | 162 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2013 | 138 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2015 | 406 | 0.020 |
Why?
|
| Glutamine | 1 | 2013 | 222 | 0.020 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 205 | 0.020 |
Why?
|
| Time Factors | 2 | 2013 | 6519 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2013 | 365 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 243 | 0.020 |
Why?
|
| Lung | 1 | 2020 | 1553 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 339 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3373 | 0.020 |
Why?
|
| Estradiol | 1 | 2014 | 550 | 0.020 |
Why?
|
| Transgenes | 1 | 2013 | 345 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 438 | 0.020 |
Why?
|
| Morpholines | 1 | 2012 | 64 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2012 | 59 | 0.020 |
Why?
|
| Genome, Human | 2 | 2009 | 1344 | 0.020 |
Why?
|
| Luminescence | 1 | 2011 | 18 | 0.020 |
Why?
|
| Quinolines | 1 | 2012 | 109 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 657 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2012 | 234 | 0.020 |
Why?
|
| Metabolome | 1 | 2013 | 309 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 5166 | 0.020 |
Why?
|
| Adult | 3 | 2020 | 31578 | 0.020 |
Why?
|
| Histone Deacetylases | 2 | 2002 | 122 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 1396 | 0.020 |
Why?
|
| Imidazoles | 1 | 2012 | 218 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2012 | 151 | 0.020 |
Why?
|
| Risk Factors | 1 | 2025 | 10923 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2011 | 471 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 971 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2016 | 727 | 0.020 |
Why?
|
| Proteasome Inhibitors | 1 | 2009 | 65 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2012 | 499 | 0.020 |
Why?
|
| Receptor, trkC | 1 | 2008 | 4 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 7133 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 1048 | 0.020 |
Why?
|
| Hydro-Lyases | 1 | 2008 | 9 | 0.020 |
Why?
|
| Phenotype | 1 | 2018 | 4491 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 2785 | 0.020 |
Why?
|
| Co-Repressor Proteins | 1 | 2008 | 38 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 306 | 0.020 |
Why?
|
| Mitochondria | 1 | 2013 | 737 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3605 | 0.020 |
Why?
|
| Cerebellum | 1 | 2012 | 458 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3970 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2013 | 1014 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 215 | 0.020 |
Why?
|
| Retroviridae | 1 | 2008 | 198 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 1064 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 1295 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 88 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 119 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 1838 | 0.010 |
Why?
|
| Genes | 1 | 2004 | 450 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2004 | 270 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 912 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 2002 | 26 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 21397 | 0.010 |
Why?
|
| Histone Deacetylase 1 | 1 | 2002 | 22 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2002 | 105 | 0.010 |
Why?
|
| Response Elements | 1 | 2002 | 106 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 2001 | 37 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 2001 | 99 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2001 | 111 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2001 | 200 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 783 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 1090 | 0.010 |
Why?
|
| Virus Replication | 1 | 2001 | 632 | 0.010 |
Why?
|